Found: 21
Select item for more details and to access through your institution.
Identification of metabolic pathways contributing to ER<sup>+</sup> breast cancer disparities using a machine-learning pipeline.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-39215-1
- By:
- Publication type:
- Article
Identification of a novel ER-NFĸB-driven stem-like cell population associated with relapse of ER+ breast tumors.
- Published in:
- Breast Cancer Research, 2022, v. 24, n. 1, p. 1, doi. 10.1186/s13058-022-01585-1
- By:
- Publication type:
- Article
Emerging Roles of Ceramides in Breast Cancer Biology and Therapy.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 19, p. 11178, doi. 10.3390/ijms231911178
- By:
- Publication type:
- Article
Estrogen Receptor-Regulated Gene Signatures in Invasive Breast Cancer Cells and Aggressive Breast Tumors.
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 2848, doi. 10.3390/cancers14122848
- By:
- Publication type:
- Article
Endocrine Therapy-Resistant Breast Cancer Cells Are More Sensitive to Ceramide Kinase Inhibition and Elevated Ceramide Levels Than Therapy-Sensitive Breast Cancer Cells.
- Published in:
- Cancers, 2022, v. 14, n. 10, p. 2380, doi. 10.3390/cancers14102380
- By:
- Publication type:
- Article
Selective pressure of endocrine therapy activates the integrated stress response through NFκB signaling in a subpopulation of ER positive breast cancer cells.
- Published in:
- Breast Cancer Research, 2022, v. 24, n. 1, p. 1, doi. 10.1186/s13058-022-01515-1
- By:
- Publication type:
- Article
Update on the Role of NFκB in Promoting Aggressive Phenotypes of Estrogen Receptor–Positive Breast Cancer.
- Published in:
- Endocrinology, 2020, v. 161, n. 10, p. 1, doi. 10.1210/endocr/bqaa152
- By:
- Publication type:
- Article
Removal of Serum Lipids and Lipid‐Derived Metabolites to Investigate Breast Cancer Cell Biology.
- Published in:
- Proteomics, 2019, v. 19, n. 18, p. N.PAG, doi. 10.1002/pmic.201800370
- By:
- Publication type:
- Article
Front Cover: Removal of Serum Lipids and Lipid‐Derived Metabolites to Investigate Breast Cancer Cell Biology.
- Published in:
- Proteomics, 2019, v. 19, n. 18, p. N.PAG, doi. 10.1002/pmic.201970161
- By:
- Publication type:
- Article
Structurally Diverse Histone Deacetylase Photoreactive Probes: Design, Synthesis, and Photolabeling Studies in Live Cells and Tissue.
- Published in:
- ChemMedChem, 2019, v. 14, n. 11, p. 1096, doi. 10.1002/cmdc.201900114
- By:
- Publication type:
- Article
Fatostatin induces pro- and anti-apoptotic lipid accumulation in breast cancer.
- Published in:
- Oncogenesis, 2018, v. 7, n. 8, p. 1, doi. 10.1038/s41389-018-0076-0
- By:
- Publication type:
- Article
Design, Synthesis, Molecular Modeling, and Biological Evaluation of Novel Amine-based Histone Deacetylase Inhibitors.
- Published in:
- ChemMedChem, 2017, v. 12, n. 24, p. 2030, doi. 10.1002/cmdc.201700449
- By:
- Publication type:
- Article
Scaffold dependent histone deacetylase (HDAC) inhibitor induced re-equilibration of the subcellular localization and post-translational modification state of class I HDACs.
- Published in:
- PLoS ONE, 2017, v. 12, n. 10, p. 1, doi. 10.1371/journal.pone.0186620
- By:
- Publication type:
- Article
Racial disparity in survival from estrogen and progesterone receptor-positive breast cancer: implications for reducing breast cancer mortality disparities.
- Published in:
- Breast Cancer Research & Treatment, 2017, v. 163, n. 2, p. 321, doi. 10.1007/s10549-017-4166-z
- By:
- Publication type:
- Article
Correlative Analysis of miRNA Expression and Oncotype Dx Recurrence Score in Estrogen Receptor Positive Breast Carcinomas.
- Published in:
- PLoS ONE, 2015, v. 10, n. 12, p. 1, doi. 10.1371/journal.pone.0145346
- By:
- Publication type:
- Article
A novel aspirin prodrug inhibits NFκB activity and breast cancer stem cell properties.
- Published in:
- 2015
- By:
- Publication type:
- journal article
14-3-3ζ as a predictor of early time to recurrence and distant metastasis in hormone receptor-positive and -negative breast cancers.
- Published in:
- Breast Cancer Research & Treatment, 2013, v. 137, n. 3, p. 689, doi. 10.1007/s10549-012-2390-0
- By:
- Publication type:
- Article
An Integrated Bioinformatics Approach Identifies Elevated Cyclin E2 Expression and E2F Activity as Distinct Features of Tamoxifen Resistant Breast Tumors.
- Published in:
- PLoS ONE, 2011, v. 6, n. 7, p. 1, doi. 10.1371/journal.pone.0022274
- By:
- Publication type:
- Article
Structure-Activity Relationships for a Family of Benzothiophene Selective Estrogen Receptor Modulators Including Raloxifene and Arzoxifene.
- Published in:
- ChemMedChem, 2007, v. 2, n. 10, p. 1520, doi. 10.1002/cmdc.200700104
- By:
- Publication type:
- Article
Expression of Prolactin and Its Receptor in the Baboon Uterus during the Menstrual Cycle and Pregnancy.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 1999, v. 84, n. 9, p. 3344, doi. 10.1210/jcem.84.9.5948
- By:
- Publication type:
- Article
Fertilization and early embryology: Comparison of mouse embryo development in open and microdrop co-culture systems.
- Published in:
- Human Reproduction, 1996, v. 11, n. 10, p. 2223, doi. 10.1093/oxfordjournals.humrep.a019081
- By:
- Publication type:
- Article